Welch & Forbes LLC Becton Dickinson & CO Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Welch & Forbes LLC holds 69,065 shares of BDX stock, worth $15.8 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

69,065

Previous 74,591 7.41%

Holding current value

$15.8 Million

Previous $17.4 Million 4.48%

% of portfolio

0.22%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$221.47 - $242.41 $1.22 Million - $1.34 Million	-5,526 Reduced 7.41%	69,065 $16.7 Million
Q2 2024 Aug 01, 2024	SELL	$225.07 - $246.17 $2.28 Million - $2.5 Million	-10,151 Reduced 11.98%	74,591 $17.4 Million
Q1 2024 May 02, 2024	SELL	$233.45 - $247.73 $488,844 - $518,746	-2,094 Reduced 2.41%	84,742 $21 Million
Q4 2023 Feb 06, 2024	SELL	$232.24 - $267.23 $147,240 - $169,423	-634 Reduced 0.72%	86,836 $21.2 Million
Q3 2023 Nov 02, 2023	SELL	$254.9 - $283.59 $2,803 - $3,119	-11 Reduced 0.01%	87,470 $22.6 Million
Q2 2023 Jul 28, 2023	SELL	$238.39 - $265.32 $372,365 - $414,429	-1,562 Reduced 1.75%	87,481 $23.1 Million
Q1 2023 Apr 14, 2023	SELL	$229.71 - $259.35 $139,663 - $157,684	-608 Reduced 0.68%	89,043 $22 Million
Q4 2022 Feb 02, 2023	SELL	$218.29 - $256.91 $23,575 - $27,746	-108 Reduced 0.12%	89,651 $22.8 Million
Q3 2022 Oct 28, 2022	BUY	$51.03 - $264.23 $5,409 - $28,008	106 Added 0.12%	89,759 $20 Million
Q2 2022 Jul 22, 2022	SELL	$234.74 - $275.42 $70,656 - $82,901	-301 Reduced 0.33%	89,653 $22.1 Million
Q1 2022 Apr 25, 2022	BUY	$243.64 - $270.48 $203,683 - $226,121	836 Added 0.94%	89,954 $23.9 Million
Q4 2021 Jan 19, 2022	BUY	$230.08 - $250.94 $30,140 - $32,873	131 Added 0.15%	89,118 $22.4 Million
Q3 2021 Oct 13, 2021	SELL	$232.72 - $256.47 $45,845 - $50,524	-197 Reduced 0.22%	88,987 $21.9 Million
Q2 2021 Jul 22, 2021	BUY	$232.65 - $254.58 $99,574 - $108,960	428 Added 0.48%	89,184 $21.7 Million
Q1 2021 Apr 14, 2021	BUY	$232.09 - $256.88 $236,963 - $262,274	1,021 Added 1.16%	88,756 $21.6 Million
Q4 2020 Jan 20, 2021	BUY	$221.92 - $245.94 $580,320 - $643,133	2,615 Added 3.07%	87,735 $22 Million
Q3 2020 Oct 23, 2020	BUY	$215.77 - $276.76 $832,009 - $1.07 Million	3,856 Added 4.75%	85,120 $19.8 Million
Q2 2020 Jul 15, 2020	BUY	$219.9 - $263.41 $239,471 - $286,853	1,089 Added 1.36%	81,264 $19.4 Million
Q1 2020 Apr 17, 2020	BUY	$195.69 - $279.01 $919,547 - $1.31 Million	4,699 Added 6.23%	80,175 $18.4 Million
Q4 2019 Jan 17, 2020	BUY	$236.45 - $266.82 $113,496 - $128,073	480 Added 0.64%	75,476 $20.5 Million
Q3 2019 Oct 11, 2019	SELL	$230.58 - $256.08 $435,335 - $483,479	-1,888 Reduced 2.46%	74,996 $19 Million
Q2 2019 Jul 12, 2019	SELL	$217.4 - $246.08 $1.16 Million - $1.31 Million	-5,320 Reduced 6.47%	76,884 $19.4 Million
Q1 2019 Apr 29, 2019	SELL	$206.05 - $248.17 $106,733 - $128,552	-518 Reduced 0.63%	82,204 $20.5 Million
Q4 2018 Feb 05, 2019	BUY	$204.73 - $257.93 $668,648 - $842,399	3,266 Added 4.11%	82,722 $18.6 Million
Q3 2018 Oct 17, 2018	SELL	$233.07 - $256.0 $188,320 - $206,848	-808 Reduced 1.01%	79,456 $20.7 Million
Q2 2018 Jul 16, 2018	BUY	$208.1 - $233.85 $258,668 - $290,675	1,243 Added 1.57%	80,264 $19.2 Million
Q1 2018 Apr 12, 2018	BUY	$205.46 - $240.27 $196,419 - $229,698	956 Added 1.22%	79,021 $17.1 Million
Q4 2017 Jan 26, 2018	BUY	$189.0 - $222.64 $316,764 - $373,144	1,676 Added 2.19%	78,065 $16.7 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $14.3 Million - $15.2 Million	76,389	76,389 $15 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account